# FDA 483 - Brock A. Andersen, M.D. - May 20, 2022

Source: https://www.globalkeysolutions.net/records/483/brock-a-andersen-md/8fd8e161-9168-4e34-b5af-82ee7c066392

> FDA 483 for Brock A. Andersen, M.D. on May 20, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Brock A. Andersen, M.D.
- Inspection Date: 2022-05-20
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West VI
- Summary: Brock A. Andersen, a clinical investigator in Fruitland, ID, was cited for significant deviations during a human clinical study of an investigational drug. The inspection revealed failures in adhering to the investigational plan, including issues with subject eligibility, study drug storage and administration, and other protocol deviations. Additionally, the firm failed to maintain adequate and accurate case histories and informed consent documents.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/sherri-n-rohlf/41090ab1-83d1-4e95-92ea-0cfca5cecdb6)

Company: https://www.globalkeysolutions.net/companies/brock-a-andersen-md/5bf1fe62-3e6e-4038-b8e1-2cb9d9db4988

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-vi/6e5a2a08-f464-4979-a759-7b0383370822